CIPO Patents = 1

EPO Patents = 4

Forward Citations = 4

Loading Chart...

2 inventors (with patents filed for the assignee):

Noa Shelach (5 out of 6 patents)

Noa Lowenton-Spier (1 out of 1 patent)

Galit Zelinger (0 patent)

5 patents: Sort by Forward Citations

1. 11439648 - Use of topical BRAF inhibitor compositions for treatment of radiation dermatitis (2022-09-13),

2. 11339163 - BRaf inhibitors and use thereof for treatment of cutaneous reactions (2022-05-24),

3. 11197861 - Methods of screening BRaf inhibitors for treating cutaneous reactions (2021-12-14),

4. 10927112 - BRaf inhibitors and use thereof for treatment of cutaneous reactions (2021-02-23),

5. 10632123 - Use of BRaf inhibitors for treating cutaneous reactions (2020-04-28),

Company Overview

Lutris Pharma Ltd. is a leading pharmaceutical company specializing in the development and commercialization of innovative medicines. With a strong focus on research and development, Lutris Pharma is committed to improving the lives of patients through cutting-edge drug formulations and therapies. Our team of scientific experts and industry professionals work tirelessly to bring novel treatment options to market, with a passion for driving advancements in healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#218 in Tel Aviv

#1,197 in Israel

Tel Aviv, Israel

Lutris Pharma Ltd.

Forward Citations = 4

2 inventors:

Noa Shelach (5 out of 6 patents)

Noa Lowenton-Spier (1 out of 1 patent)

Galit Zelinger (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lutris Pharma Ltd.. Retrieved from https://idiyas.com/company/lutris-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]